Servier Integrates Definiens Technology in Translational Research
17-Apr-2008
Brian Lockhart, Director of Servier's Division Molecular Pharmacology and Pathophysiology: "In order to put molecular histopathology at the core of Servier's drug discovery programs, the decision to integrate Definiens' innovative and robust Definiens Enterprise Image Intelligence(TM) Suite is a critical step in the success of this strategy."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.